Kirk Daffner, M.D. and Margaret O’Connor, Ph.D. were featured in the story, “You can no longer drive, and good luck’: Figuring out how long it’s safe to drive has become the third rail of aging.”

Cognitive neurologist sees value in age-focused conversations around Biden’s exit, but also a lack of nuance

Study suggests genetics are a cause, not just a risk for some with Alzheimer’s.

Patients planning to receive anti-amyloid treatments such as lecanemab first must enroll in a registry to help clinicians draw conclusions on the drugs’ safety and efficacy.